Orexin and Alzheimer’s Disease: A New Perspective

다국어 초록 (Multilingual Abstract)

Orexin’s role in human cognition has recently been emphasized and emerging evidences indicate its close relationship with Alzheimer’s disease (AD). This review aimed to demonstrate recent research on the relationship between orexin and AD. Orexin’s role in stress regulation and memory is discussed, with significant findings related to sexual disparities in stress response, with potential clinical implications pertaining to AD pathology. There are controversies regarding the orexin levels in AD patients, but the role of orexin in the trajectory of AD is still emphasized in recent literatures. Orexin is also accentuated in the context of tau pathology, and orexin as a potential therapeutic target for AD is frequently discussed. Future directions with regard to the relationship between orexin and AD are suggested: 1) consideration for AD trajectory in the measurement of orexin levels, 2) the need for objective measure such as polysomnography and actigraphy, 3) the need for close observation of cognitive profiles of orexin-deficient narcolepsy patients, 4) the need for validation studies by neuroimaging 5) the need for taking account sexual disparities in orexinergic activiation, and 6) consideration for orexin’s role as a stress regulator. The aforementioned new perspectives could help unravel the relationship between orexin and AD.

참고문헌 (Reference)

1 Willie JT, "To eat or to sleep? Orexin in the regulation of feeding and wakefulness" 24 : 429-458, 2001

2 Villa C, "The synergistic relationship between Alzheimer’s disease and sleep disorders : an update" 46 : 571-580, 2015

3 Lin L, "The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin(orexin)receptor 2 gene" 98 : 365-376, 1999

4 Akbari E, "The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze" 28 : 650-656, 2007

5 Sargin D, "The role of the orexin system in stress response" 154 : 68-78, 2019

6 Song J, "The role of orexin in post-stroke inflammation, cognitive decline, and depression" 8 : 16-, 2015

7 McHill AW, "The relationship between estrogen and the decline in delta power during adolescence" 40 : 2017

8 Chen Q, "The hypocretin/orexin system : an increasingly important role in neuropsychiatry" 35 : 152-197, 2015

9 Peineau S, "Synaptic plasticity modulation by circulating peptides and metaplasticity : involvement in Alzheimer’s disease" 130 : 385-401, 2018

10 Mander BA, "Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer’s disease?" 39 : 552-566, 2016

11 Van Egroo M, "Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer’s disease" 42 : pii:zsz017-, 2019

12 Erik S Musiek, "Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease" 생화학분자생물학회 47 : 1-8, 2015

13 Holth J, "Sleep in Alzheimer’s disease-beyond amyloid" 2 : 4-14, 2017

14 Shi L, "Sleep disturbances increase the risk of dementia : a systematic review and meta-analysis" 40 : 4-16, 2018

15 Spira AP, "Sleep disturbance: an emerging opportunity for Alzheimer’s disease prevention?" 29 : 529-531, 2017

16 Minakawa EN, "Sleep disturbance as a potential modifiable risk factor for Alzheimer’s disease" 20 : pii: E803-, 2019

17 Olsson M, "Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer’s disease" 41 : 2018

18 Pike CJ, "Sex and the development of Alzheimer’s disease" 95 : 671-680, 2017

19 Grafe LA, "Reduced orexin system function contributes to resilience to repeated social stress" 5 : 2018

20 Gabelle A, "Reduced brain amyloid burden in elderly patients with narcolepsy type 1" 85 : 74-83, 2019

21 Burdakov D, "Reactive and predictive homeostasis : roles of orexin/hypocretin neurons" 154 : 61-67, 2019

22 Mavanji V, "Promotion of wakefulness and energy expenditure by orexin-A in the ventrolateral preoptic area" 38 : 1361-1370, 2015

23 Huang H, "Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin : a feedforward circuit that may enhance cognitive arousal" 95 : 1656-1668, 2006

24 Roh JH, "Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease" 211 : 2487-2496, 2014

25 El-Sedeek M, "Plasma orexin-A levels in postmenopausal women : possible interaction with estrogen and correlation with cardiovascular risk status" 117 : 488-492, 2010

26 Gervais NJ, "Ovarian hormones, sleep and cognition across the adult female lifespan : an integrated perspective" 47 : 134-153, 2017

27 Grafe LA, "Orexins mediate sex differences in the stress response and in cognitive flexibility" 81 : 683-692, 2017

28 Grafe LA, "Orexins and stress" 51 : 132-145, 2018

29 Liguori C, "Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease" 71 : 1498-1505, 2014

30 Summers CH, "Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making : Potential for therapy" 1731 : 146085-, 2020

31 Fadel J, "Orexin/hypocretin modulation of the basal forebrain cholinergic system : role in attention" 1314 : 112-123, 2010

32 Fadel J, "Orexin/hypocretin modulation of the basal forebrain cholinergic system : insights from in vivo microdialysis studies" 90 : 156-162, 2008

33 Walling SG, "Orexin-A infusion in the locus ceruleus triggers norepinephrine(NE)release and NE-induced long-term potentiation in the dentate gyrus" 24 : 7421-7426, 2004

34 Li M, "Orexin-A exacerbates Alzheimer’s disease by inducing mitochondrial impairment" 718 : 134741-, 2020

35 Ma Z, "Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer’s disease-risk genes" 6 : 36035-, 2016

36 Eacret D, "Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory" 356 : 444-452, 2019

37 Piantadosi PT, "Orexin receptor activity in the basal forebrain alters performance on an olfactory discrimination task" 1594 : 215-222, 2015

38 Ishibashi M, "Orexin receptor activation generates gamma band input to cholinergic and serotonergic arousal system neurons and drives an intrinsic Ca(2+)-dependent resonance in LDT and PPT cholinergic neurons" 6 : 120-, 2015

39 Ji MJ, "Orexin prevents depressivelike behavior by promoting stress resilience" 24 : 282-293, 2019

40 Dang R, "Orexin knockout mice exhibit impaired spatial working memory" 668 : 92-97, 2018

41 An H, "Orexin impairs the phagocytosis and degradation of amyloid-beta fibrils by microglial cells" 58 : 253-261, 2017

42 Soya S, "Orexin as a modulator of fear-related behavior : hypothalamic control of noradrenaline circuit" 1731 : 146037-, 2020

43 Liguori C, "Orexin and Alzheimer’s disease" 33 : 305-322, 2017

44 Shi L, "Orexin A differentially influences the extinction retention of recent and remote fear memory" 12 : 295-, 2018

45 Ardeshiri MR, "Orexin 1 and orexin 2 receptor antagonism in the basolateral amygdala modulate long-term potentiation of the population spike in the perforant path-dentate gyrus-evoked field potential in rats" 149 : 98-106, 2018

46 Kornum BR, "Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain" 21 : 897-903, 2011

47 Cole S, "Medial prefrontal cortex neural plasticity, orexin receptor 1 signaling, and connectivity with the lateral hypothalamus are necessary in cue-potentiated feeding" 40 : 1744-1755, 2020

48 Lleó A, "Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer’s disease continuum in the BIOMARKAPD study" 15 : 742-753, 2019

49 Macedo AC, "Is sleep disruption a risk factor for Alzheimer’s disease?" 58 : 993-1002, 2017

50 Gallone S, "Is HCRTR2 a genetic risk factor for Alzheimer’s disease" 38 : 245-253, 2014

51 Calva CB, "Intranasal administration of orexin peptides : mechanisms and therapeutic potential for age-related cognitive dysfunction" 1731 : 145921-, 2020

52 Chang H, "Inhibitory effects of an orexin-2 receptor antagonist on orexin A-and stress-induced ACTH responses in conscious rats" 57 : 462-466, 2007

53 Joffe H, "Independent contributions of nocturnal hot flashes and sleep disturbance to depression in estrogen-deprived women" 101 : 3847-3855, 2016

54 Vittoz NM, "Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex : involvement of the ventral tegmental area" 31 : 384-395, 2006

55 Fronczek R, "Hypocretin(orexin)loss in Alzheimer’s disease" 33 : 1642-1650, 2012

56 Vittoz NM, "Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons" 28 : 1629-1640, 2008

57 Burdakov D, "How orexin signals bias action : hypothalamic and accumbal circuits" 1731 : 145943-, 2020

58 Lucey BP, "How amyloid, sleep and memory connect" 18 : 933-934, 2015

59 Bahramzadeh Zoeram S, "Hippocampal orexin receptor blocking prevented the stress induced social learning and memory deficits" 157 : 12-23, 2019

60 Duffy CM, "High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss" 157 : 41-47, 2019

61 Roh J, "Gene Therapy in Neurological Disorders" Elsevier, Academic Press 163-175, 2018

62 Jiyoung Lyu, "Gender-Specific Incidence and Predictors of Cognitive Impairment among Older Koreans: Findings from a 6-Year Prospective Cohort Study" 대한신경정신의학회 13 (13): 473-479, 2016

63 Fadel JR, "Food for thought : the role of appetitive peptides in age-related cognitive decline" 12 : 764-776, 2013

64 Wang C, "Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease" 6 : 20352-, 2016

65 Merlo S, "Estrogen and Alzheimer’s disease : still an attractive topic despite disappointment from early clinical results" 817 : 51-58, 2017

66 Tansupswatdikul P, "Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms : a randomized trial" 18 : 198-204, 2015

67 Prober DA, "Discovery of hypocretin/orexin ushers in a new era of sleep research" 41 : 70-72, 2018

68 Gozzi A, "Differential effect of orexin-1 and CRF-1 antagonism on stress circuits : a fMRI study in the rat with the pharmacological stressor Yohimbine" 38 : 2120-2130, 2013

69 Arias-Carrion O, "Depletion of hypocretin/orexin neurons increases cell proliferation in the adult subventricular zone" 17 : 106-112, 2018

70 Baykal S, "Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder" 40 : 593-602, 2019

71 Schmidt FM, "Cerebrospinal fluid melanin-concentrating hormone(MCH)and hypocretin-1(HCRT-1, orexin-A)in Alzheimer’s disease" 8 : e63136-, 2013

72 Jennum PJ, "Cerebrospinal fluid biomarkers of neurodegeneration are decreased or normal in narcolepsy" 40 : 2017

73 Al-Barazanji KA, "Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats" 13 : 421-424, 2001

74 Hansson O, "CSF biomarkers of Alzheimer’s disease concord with amyloid-βPET and predict clinical progression : a study of fully automated immunoassays in BioFINDER and ADNI cohorts" 14 : 1470-1481, 2018

75 Blake MG, "Basal forebrain cholinergic system and memory" 37 : 253-273, 2018

76 Slats D, "Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer’s disease and healthy controls" 9 : 1119-1125, 2012

77 Kang JE, "Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle" 326 : 1005-1007, 2009

78 Liu Z, "Amyloid β and tau are involved in sleep disorder in Alzheimer’s disease by orexin A and adenosine A(1)receptor" 43 : 435-442, 2019

79 Stanley EM, "Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system" 66 : 445-452, 2012

80 Kessler BA, "Age-related loss of orexin/hypocretin neurons" 178 : 82-88, 2011